Market Overview:

The global Cancer Biomarkers Marketwas valued at USD 10.19 billion in 2016 and is projected to reach USD 28.03billion by 2025, growing at a CAGR of 11.9% from 2017 to 2025.
Cancer Biomarkers have high usage in Cancer diagnostics and treatment, especially in Tissue specific therapies. Therefore market of this genetically engineered product is seeing high values in terms of market value.

Sample Infographics:




Market Dynamics:
1. Market Drivers
1.1 Increasing Technological Developments
1.2 Growingnumber of cancer Patients and usage of biomarkers
1.3 Increasing research in biomarkers
2. Market Restraints
2.1 Reimbursements Risks
2.2 High investment and uncertainty of favorable profits
2.3 Technicality concerns

Market Segmentation:
1. Global Cancer Biomarkers Market, by Application:
1.1 Diagnostics
1.2 Research and Development
1.3 Prognostics
1.4 Risk Assessment
1.5 Other Applications

2. Global Cancer Biomarkers Market, by Cancer Type:
2.1 Breast Cancer
2.2 Lung Cancer
2.3 Colorectal Cancer
2.4 Prostate Cancer
2.5 Non-Hodgkin’s Lymphoma
2.6 Melanoma
2.7 Leukemia
2.8 Thyroid Cancer
2.9 Bladder Cancer
2.10 Kidney Cance
2.11 Other Cancer Types

3. Global Cancer Biomarkers Market, by Profiling Technology:
3.1 Omics Technologies
3.1.1 Proteomics
3.1.2 Genomics
3.1.2.1 Next-Generation Sequencing (NGS)
3.1.2.2 Polymerase Chain Reaction (PCR)
3.1.3 Other Omics Technologies
3.2 Imaging Technologies
3.2.1 Ultrasound
3.2.2 Computed Tomography (Ct)
3.2.3 Magnetic Resonance Imaging (Mri)
3.2.4 Positron Emission Tomography (Pet)
3.2.5 Mammography
3.3 Immunoassays
3.4 Cytogenetics
3.4.1 in Situ Hybridization (Ish)
3.4.2 Other Cytogenetics-Based Tests
3.5 Bioinformatics

4. Global Cancer Biomarkers Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific
2. Bio-Rad Laboratories
3. Roche Diagnostics
4. Qiagen N.V.
5. Illumina
6. GE Healthcare
7. Agilent Technologies
8. Biomérieux SA
9. Merck & Co.
10. Abbott Laboratories
11. Becton, Dickinson and Company
12. Danaher Corporation
13. Myriad Genetics
14. Sysmex Corporation
15. Hologic
16. Quest Diagnostics

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cancer Biomarkers Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL CANCER BIOMARKERS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CANCER BIOMARKERS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION
5.1 Diagnostics
5.2 Research and Development
5.3 Prognostics
5.4 Risk Assessment
5.5 Other Applications

6 GLOBAL CANCER BIOMARKERS MARKET, BY CANCER TYPE
6.1 Breast Cancer
6.2 Lung Cancer
6.3 Colorectal Cancer
6.4 Prostate Cancer
6.5 Non-Hodgkin’s Lymphoma
6.6 Melanoma
6.7 Leukemia
6.8 Thyroid Cancer
6.9 Bladder Cancer
6.10 Kidney Cancer
6.11 Other Cancer Types

7 GLOBAL CANCER BIOMARKERS MARKET, BY PROFILING TECHNOLOGY
7.1 Omics Technologies
7.1.1 Proteomics
7.1.2 Genomics
7.1.3 Other Omics Technologies

7.2 Imaging Technologies
7.2.1 Ultrasound
7.2.2 Computed Tomography (Ct)
7.2.3 Magnetic Resonance Imaging (Mri)
7.2.4 Positron Emission Tomography (Pet)
7.2.5 Mammography

7.3 Immunoassays

7.4 Cytogenetics
7.4.1 in Situ Hybridization (Ish)
7.4.2 Other Cytogenetics-Based Tests
7.5 Bioinformatics

8 GLOBAL CANCER BIOMARKERS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL CANCER BIOMARKERS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Thermo Fisher Scientific
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Bio-Rad Laboratories
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Roche Diagnostics
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Qiagen N.V.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Illumina
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 GE Healthcare
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Agilent Technologies
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Biomérieux SA
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Merck & Co.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Abbott Laboratories
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Becton, Dickinson and Company
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Danaher Corporation
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

10.13 Myriad Genetics
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments

10.14 Sysmex Corporation
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments

10.15 Hologic
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments

11 Appendix
11.1 Related Reports

Asia Pacific Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Photodynamic Therapy Market is on the brink of significant growth, driven by increasing cancer prevalence, advancements in Photodynamic Therapy technology, and rising awareness about minimally invasive treatment options. Market research indicates a robus...

Europe Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Photodynamic Therapy Market is poised for substantial growth in the coming decade, propelled by increasing cancer incidence, advancements in photodynamic therapy technology, and heightened awareness of minimally invasive treatments. Market research forecasts t...

North America Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Photodynamic Therapy Market is projected to witness substantial growth in the coming decade, driven by the rising prevalence of cancer, advancements in Photodynamic Therapy technology, and increasing awareness of minimally invasive treatments. Market re...

Global Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Photodynamic Therapy Market is poised to experience substantial growth in the coming decade, driven by the rising prevalence of cancer and other chronic diseases, advancements in PDT technology, and increasing awareness of minimally invasive treatment options....

Cancer-focused Genetic Testing Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cancer-focused Genetic Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...

Anti-cancer Drug Exposure Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Anti-cancer Drug Exposure Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...

Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Non-Small Cell Lung Cancer Treatment (NSCLC) Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive l...

Breast Cancer Hormone Therapy Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Breast Cancer Hormone Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...

Metastatic Colorectal Cancer Drug Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Metastatic Colorectal Cancer Drug Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...

Cervical Cancer Screening Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cervical Cancer Screening Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...